Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma of Lung

Explore clinical trials studying Adenocarcinoma of Lung. Study availability and eligibility vary by location and protocol.

266 public trials 48 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma of Lung trial results

Completed

Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung Cancer

NCT00950365

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +19 more
Locations
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • University of Massachusetts Memorial Health Care Worcester, Massachusetts, United States
  • Albert Einstein College of Medicine The Bronx, New York, United States
  • Bronx River Medical Associates PC The Bronx, New York, United States
View Trial Details
Completed

A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the Lung

NCT01218516

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of the Lung, +8 more
Locations
  • Ironwood Cancer and Research Center Chandler, Arizona, United States
  • Arizona Center for Hematology Oncology Glendale, Arizona, United States
  • Providence Health System Beverly Hills, California, United States
  • Cancer Care Associates of Fresno Medical Group, Inc. Fresno, California, United States
View all 93 locations
View Trial Details
Completed

Radiation Therapy to Relieve Symptoms in Patients With Non-small Cell Lung Cancer

NCT00003685

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +24 more
Locations
  • Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • British Columbia Cancer Agency - Fraser Valley Cancer Centre Surrey, British Columbia, Canada
  • BC Cancer Agency Vancouver, British Columbia, Canada
View all 21 locations
View Trial Details
Completed

S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma

NCT00436332

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +14 more
Locations
  • Kaiser Permanente - Deer Valley Antioch, California, United States
  • Alta Bates Summit Comprehensive Cancer Center Berkeley, California, United States
  • Peninsula Medical Center Burlingame, California, United States
  • Kaiser Permanente - Fremont Fremont, California, United States
View all 148 locations
View Trial Details
Completed

S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer

NCT00445848

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +13 more
Locations
  • Kaiser Permanente - Deer Valley Antioch, California, United States
  • Alta Bates Summit Comprehensive Cancer Center Berkeley, California, United States
  • Peninsula Medical Center Burlingame, California, United States
  • Kaiser Permanente - Fremont Fremont, California, United States
View all 153 locations
View Trial Details

Related conditions